Ectopically expressed human KV10.1 channels are relevant players in tumor biology. However, their function as ion channels at the plasma membrane does not totally explain their crucial role in tumors. Both in native and heterologous systems, it has been observed that a majority of KV10.1 channels remain at intracellular locations. In this study we investigated the localization and possible roles of perinuclear KV10.1. We show that KV10.1 is expressed at the inner nuclear membrane in both human and rat models; it co-purifies with established inner nuclear membrane markers, shows resistance to detergent extraction and restricted mobility, all of them typical features of proteins at the inner nuclear membrane. KV10.1 channels at the inner nuclear membrane are not all transported directly from the ER but rather have been exposed to the extracellular milieu. Patch clamp experiments on nuclei devoid of external nuclear membrane reveal the existence of channel activity compatible with KV10.1. We hypothesize that KV10.1 channels at the nuclear envelope might participate in the homeostasis of nuclear K+, or indirectly interact with heterochromatin, both factors known to affect gene expression.
Citation: Chen Y, Sánchez A, Rubio ME, Kohl T, Pardo LA, Stühmer W (2011) Functional KV10.1 Channels Localize to the Inner Nuclear Membrane. PLoS ONE 6(5): e19257. doi:10.1371/journal.pone.0019257
Editor: Sven G. Meuth, University of Muenster, Germany
Received: October 22, 2010; Accepted: March 31, 2011; Published: May 3, 2011
Copyright: © 2011 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Max-Planck Gesselschaft, NEUREST (MEST-CT-2004-504193), R01 DC-006881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
KV10.1 (Ether-à-go-go-1, KCNH1) is a voltage-gated potassium channel expressed almost exclusively in the mammalian central nervous system, where its physiological roles have not been clearly identified. Intriguingly, over 70% human tumors of various origins show KV10.1 expression , , , , , ,  the intensity of which correlates negatively with survival in some sarcomas  and leukemias . It has also been shown that KV10.1 not only plays a role in oncogenic transformation and malignancy, but also that the proliferation of cancer cells is dependent on its expression . It nevertheless remains unclear if K+ permeation is required for the carcinogenic properties of KV10.1. On one hand, a KV10.1 open channel blocker  and a monoclonal antibody against KV10.1  both of which inhibit ion flow, are able to reduce xenograft tumor growth in immunodeficient mice. On the other hand, the Drosophila ortholog eag is also known to induce an increase in cell proliferation independently of ion influx , and a non-conducting KV10.1 point mutant still promotes tumor progression, although to a reduced extent . Also, not every K+ channel shows a similar behavior. For example, KV10.5, the closest relative to KV10.1, possesses very similar electrophysiological properties, but is not carcinogenic .
Interactions of the channels with signaling cascades within the cell could explain these effects without ion permeation. This is in line with the observation that the vast majority of KV10.1 protein remains in intracellular pools, including the perinuclear region, in either heterologous systems , neurons  or tumor cells . It has also been reported that KV10.1 plays a role in oxygen homeostasis and angiogenesis independently of K+ flow , which would provide an advantage to tumor cells but does not explain the observations reported in vitro.
During the eukaryotic interphase, nucleoplasm and cytoplasm constitute two distinct compartments separated by the nuclear envelope, and trafficking between compartments is allowed by the nuclear pore complex (NPC). Small (<40 KDa) soluble proteins can cross the NPC freely, while larger molecules are active and selectively transported . The nuclear envelope is a membranous structure composed of two layers, the inner and the outer nuclear membranes (INM and ONM, respectively), and the space between is termed the perinuclear space. The ONM is an extension of the ER but shows a distinct protein composition, different from that of the rest of the reticulum . Consequently, the perinuclear space is continuous with the lumen of the ER. The protein composition of the INM is radically different from that of the ONM and the ER. Only a handful of transmembrane proteins are known to reach the INM .
As a particular type of complex transmembrane protein, ion channels have also been found in the nuclear envelope . Most reports refer to channels in the ONM, while, to our knowledge, only few channels have been reported to date at INM. Marchenko et al.  describe the inositol 1,4,5-trisphosphate (InsP3) receptor, Longin et al.  a zinc and a calcium channel, Rousseau et al.  report two chloride conductances and a non-selective cation channel, and Fedorenko et al., describe a large conductance non-selective cation channel in both the ONM and the INM ; among all of them, only the InsP3 receptor has an identified molecular identity.
The permeability of the NPC to small ions is still under debate. If it would not be permeable to ions, the ionic composition should be different between the nucleoplasm and cytoplasm, and there could be an electrical potential across the nuclear envelope. However, there are few reports on the ion composition of the nucleoplasm ,  and, in most cases, the intranuclear potential is only slightly negative compared to the cytoplasm  but is still dependent on the cytoplasmic K+ concentration . On the other hand, there are compelling electrophysiological studies where it has been proposed that the NPC can close in a voltage-dependent manner in the absence of cargo, and that ion flow is prevented when the pore is occluded by cargo . This makes it possible for channels at the INM to dampen or amplify cytoplasmic Ca2+ transients into the nucleoplasm . From an experimental point of view, the existence of a diffusion barrier also allows measurement of currents from other smaller channels on either the outer or the INM. It should also be noted that the activity of channels at the INM could participate in the regulation of ion exchange between the nucleoplasm and the perinuclear space, which is continuous with the ER lumen but not the cytosol. In any case, it cannot be ruled out that such ion channels may have functions independent of ion permeation.
In the present report, we provide evidence showing that KV10.1 is located to the INM and that currents compatible with KV10.1 can be detected by patch clamp at the INM. We also show that INM KV10.1 might interact with heterochromatin. We discuss these findings in light of the role of KV10.1 in cancer, as the INM has been shown to affect gene expression, genome stability and cell senescence, all of which are relevant to cancer .
KV10.1 localizes to the perinuclear region of native and transfected cells
There is compelling electrophysiological, microscopical and biochemical evidence that KV10.1 is a plasma membrane channel. However, immunostainings of neurons, transfected cells, tumors and tumor cells, as well as in vivo observation of KV10.1 labeled with fluorescent proteins (DsRed2, EGFP and mVenus) in different cell types (NIH3T3, CHO, HEK293), revealed perinuclear localization of the protein in 53% of ts20 cells (n = 156) and 11% of CHO cells (n = 203) in the form of a thin line compatible with the nuclear envelope (Fig. 1A, B). Depending on the cell line used, there were roughly 20–40% of cells exhibiting a perinuclear staining pattern possibly indicating an unrevealed role of KV10.1 in a particular cellular function.
A. NIH3T3 cells transfected with KV10.1-DsRed (wide field epifluorescence image of living cell, 40x/0.75 Zeiss Achroplan water immersion objective). B. CHO cell transfected with KV10.1-DsRed2 (wide field epifluorescence image of living cell, 63x/0.9 Zeiss Achroplan water immersion objective). Scale bars: 5 µm. C. Confocal image showing perinuclear localization of EGFP-KV10.1DNLS (devoid of nuclear localization signal) in a living CHO cell (Zeiss LSM510Meta, Plan-Neofluar 40x/1.3 Oil DIC objective; scale bar: 10 µm). D. Two examples of co-localization of KV10.1 with lamin A/C. HeLa cells fixed with methanol were stained with goat anti human lamin A/C (Di, Dv; Alexa Fluor 546 donkey anti-goat secondary antibody) and rabbit polyclonal anti-KV10.1 (Dii, Dvi; donkey anti-rabbit FITC conjugated secondary antibody) and antibodies. Diii, Dvii merged images. Div, Dviii, Co-localization display; grayscale intensity indicates colocalization (analyzed using FiJi). Wide field epifluorescence image, 63x Zeiss Plan Apochromat 1.4 oil immersion objective. Scale bar: 10 µm. Gaussian blur (d = 2 pixel) was applied to all the images.
To confirm this observation, we performed co-localization experiments with lamin A/C as a nuclear envelope marker using double staining with antibodies in HeLa cells expressing endogenous KV10.1. A significant level of co-localization was observed (Fig. 1D). This localization is not dependent on Golgi integrity, since it is not abolished by brefeldin A (50 µM) treatment, nor does it entirely co-localize with the ER, as revealed by co-transfection of DsRed-tagged KV10.1 and a YFP-ER marker (data not shown). The C-terminus of KV10.1 exhibits a bipartite nuclear localization signal. We deleted this sequence to test its influence in the perinuclear localization of KV10.1. For this purpose, we used an EGFP-tagged version of KV10.1. The deleted mutant still preserves electrophysiological activity when expressed in Xenopus oocytes (data not shown). However, we did not observe abolition of the perinuclear signal (Fig. 1C), and therefore concluded that the identified nuclear localization signal of KV10.1 is not required for its targeting to the nuclear envelope.
In heterologous systems and tumor cells, although not in the brain, it could be argued that the expression of the channel in the nuclear envelope is an artifact of massive overexpression. If this were the case, one would expect a positive correlation between overall expression levels and INM expression. However, detailed image analysis revealed that the perinuclear fluorescence intensity of KV10.1 did not correlate with cytoplasmic intensity: 91% of ts20 cells showed higher perinuclear than cytoplasmic fluorescence intensity in the immediately neighboring region (n = 90). In 19% of cells, the perinuclear intensity was at least twice as high than the cytoplasmic one (see examples in Figure 1). Inhibition of de novo protein synthesis by cycloheximide (10 µg/mL for 1–12 hours) did not abolish the perinuclear localization, also arguing against an overexpression artifact (data not shown). This suggests that, even in overexpression systems, the localization of KV10.1 to the nuclear envelope involves a specific regulatory mechanism.
The proximity of ONM and INM (at the scale of 40 nm ) is far beyond the resolution of standard confocal microscopy. We therefore carried out post-embedding immunoelectron microscopy on samples showing endogenous KV10.1 expression using mAb62 antibodies. Approximately 90% of gold particles labeling KV10.1 channels were detected on the INM of both the human cancer cell line MCF-7 (Fig. 2A–C) and rat cerebellum (Fig. 2D–E) and hippocampus (Fig. 2F–H). The rest of gold particles were localized either in the ONM or in the adjacent cytoplasm.
The perinuclear localization of KV10.1 is compatible with the INM
The ONM is continuous with the ER, where integral membrane proteins are synthesized. These proteins could, in principle, diffuse to the ONM and result in a perinuclear distribution pattern. To distinguish between external and INM localizations, digitonin-permeabilization experiments are often employed. Digitonin preferentially permeabilizes cholesterol-rich membranes (e.g. plasma membrane) and consequently the cholesterol-poor ER and nuclear envelope membranes remain largely intact . In the selectively permeabilized cells, antibodies can only access the cytoplasmic side of ER/ONM proteins but cannot reach the INM proteins, which are shielded by the nuclear envelope. Because the ER lumen is topologically equivalent to the extracellular space, the extracellular domains of KV10.1 should face the ER lumen or the perinuclear space, while the C-terminus is expected to face the cytoplasm . Antibodies could therefore not access the INM KV10.1, regardless of its orientation, as long as the ONM is intact.
CHO cells transiently transfected with KV10.1-mVenus were permeabilized either thoroughly with Triton X-100 or selectively with digitonin, and then probed with antibodies recognizing either an extracellular loop (mAb66) or the intracellular C-terminus (mAb33) (Fig. 3). In the Triton X-100 permeabilized cells, signals from the KV10.1-mVenus channel perfectly overlapped with the immunofluorescent staining (Fig. 3 Bc,d and Cc,d). In cells permeabilized with digitonin, mAb66 was unable to label the intracellular KV10.1 (Fig. 3 Ba,b), suggesting that the integrity of ER/nuclear envelope was preserved, and that the extracellular regions of ER KV10.1 face the lumen. In contrast, mAb33 (Fig. 3 Ca,b) mostly stained the intracellular KV10.1, but failed to label KV10.1 located at the perinuclear rim, indicating that perinuclear KV10.1 localized to a subcellular compartment distinct from the ER/ONM but compatible with the INM. Consistent staining patterns were obtained in CHO cells transfected with non-tagged KV10.1 (not shown) and are therefore unlikely to be an effect of the mVenus fusion.
A. Schematic representation of the topology of KV10.1 on different (intra)cellular membranes. Two relevant domains of KV10.1 are show: the pore and intracellular C-terminus. Cells in different permeabilized states are shown with red or yellow color representing compartments that are accessible or inaccessible by antibody-containing solution, respectively. In digitonin-permeabilized cells, only the C terminal of ER/ONM KV10.1 is accessible while antibodies can reach neither the pore of ER/ONM KV10.1 nor any domain of the INM KV10.1. In Triton-permeabilized cells, all intracellular KV10.1 is accessible by antibodies. Transiently transfected CHO cells were permeabilized at 4°C by either digitonin (Ba,b; Ca,b) or Triton X-100 (Bc,d; Cc,d), then fixed and labeled with anti-KV10.1 antibody against either the pore (B) or the C-terminal (C). The corresponding fluorescence from the mVenus tagged channel in both treatments is shown in panels b and d. Gaussian blur (d = 2 pixel) was applied to all the images. Scale bar: 10 µm.
During our microscopy experiments, we noticed that perinuclear KV10.1 was unevenly distributed, rather than being a smooth line surrounding the whole nucleus. Similar discrete nuclear envelope microdomains, devoid of NPC and therefore termed ‘NPC-free islands’, have already been reported for nurim , emerin  and the lamin B receptor (LBR) , which has been shown to recruit heterochromatin. To test if the patched distribution pattern of KV10.1 corresponds to NPC-free islands, we performed double staining of KV10.1 and NPC constituents. KV10.1 frequently resided at the region of low or no NPC intensity, as indicated by a Manders Coefficient close to 0 (0.27±0.17, n = 15), although NPC is nearly ubiquitous in the nuclear envelope. Perinuclear KV10.1 was often found to be close to intense DAPI staining, which typically identifies heterochromatin (Fig. 4), also in live cells expressing KV10.1-mVenus and stained with Hoechst 33342 (not shown).
A. Representative picture of a CHO cell transiently expressing KV10.1 and stained with anti-NPC antibodies (red) and anti-KV10.1 antibodies (green). In the perinuclear region marked by the boundary of DNA stained by DAPI (blue), KV10.1 is excluded from the region containing NPC. Scale bar: 10 µm B. Enlargement of a perinuclear region from the same cell. Scale bar: 2 µm C. The perinuclear region is shown straightened to allow comparison between red and green fluorescence.
KV10.1 localization to NPC-free islands and proximity to heterochromatin may involve either a direct or an indirect interaction with heterochromatin. INM proteins in direct contact with histones can be detected in the ‘nuclear envelope-peripheral heterochromatin fraction’ . However, this was not the case for KV10.1 in the HEK-KV10.1 cell line (data not shown) and we therefore tested for indirect interactions. An indication of heterochromatin formation in the case of certain INM proteins is the loss of lamin A/C signals in immunostaining due to epitope masking , although it can also be due to phosphorylation of lamin itself , . As mentioned before, KV10.1 is localized to the same areas as lamin A/C. A closer examination revealed that, within those regions, KV10.1 was consistently localized to regions with low lamin A/C fluorescence intensity. In 11/21 cells, KV10.1 signal covered 47±5% of the perinuclear region, and there was a masking of local lamin A/C signal but no significant effect on the total intensity (compared to the average value in the same field of view); in 5 cells, KV10.1 signal covered 72±8% of the perinuclear region, and there was a global reduction of the lamin A/C fluorescence intensity-typical for “epitope masking”; in the rest of the cells, KV10.1 signal occupied 66±10% of the perinuclear region, but there was no obvious effect on lamin A/C signal (Figure 5). This reduction of fluorescence could be rescued partially by extraction with high concentration of salt or incubation with DNase I, and a combination of both treatments resulted in a nearly complete retrieval of lamin A/C fluorescence. This can be interpreted as that the presence of KV10.1 correlates with the formation of heterochromatin, either locally or globally, which further masks the epitope of lamin A/C.
CHO cells transiently expressing KV10.1-mVenus (green) were extracted in Triton X-100 (top panel) plus either DNase I (second panel from top), NaCl (third panel) on ice, or DNase I plus NaCl (bottom panel) at 37°C. Cells were then stained with anti-lamin A/C antibodies (red). Note the reduced lamin A/C fluorescence in the upper panel and the rescue in the other three panels. Scale bar, 20 µm.
Perinuclear KV10.1 is resistant to Triton X-100 extraction and shows restricted lateral mobility
Higher resistance to non-ionic detergent extraction also characterizes INM proteins. To test this, CHO cells transiently expressing KV10.1-mVenus were incubated with extraction buffer containing 3% Triton X-100 before fixation and the fluorescence obtained was examined by confocal microscopy. This extraction removed the fluorescence signals from all the cytoplasm except in the perinuclear region as compared to control cells (Fig. 6A,B). The remaining punctate cytoplasmic structures have been suggested to be aggregates resistant to extraction in similar experiments on other INM proteins . Triton X-100 extraction was also applied to isolated nuclei from HEK-KV10.1 cells and evaluated by western blotting. Efficiency of the detergent extraction of the nuclear fraction was tracked by reduction of the ER/ONM marker NADPH cytochrome c reductase. A significant amount of KV10.1 remained in the non-extracted (INM) fraction. A fraction of KV10.1 was also extracted, possibly representing the ER/ONM (or other contaminating organelles) pool of KV10.1 in this overexpression system (Fig. 6B, C).
CHO cells transfected with KV10.1-mVenus were incubated without (A) or with (B) 3% Triton X-100 for 5 min, fixed and analyzed by confocal microscopy. Triton X-100 largely extracted the cytoplasmic signal, while the perinuclear signal was still detected. Scale bar: 10 µm. C. Western blot analysis using anti-KV10.1 antibody on total cell extract, crude nuclear extract and nuclei extracted with 0.5% Triton X-100 from HEK293 cells stably expressing KV10.1. Enrichment in nuclear proteins was followed by reduction of NADPH cytochrome c reductase activity.
INM proteins are typically subjected to various interactions at the lamina layer and their lateral diffusion is therefore restricted as compared to their ER counterparts. To compare the mobility of KV10.1 in nuclear envelope and ER, we carried out 1-D FRAP experiments in CHO cells expressing KV10.1-mVenus. Two strips (2 µm wide) were bleached at both the nuclear envelope and ER, and the recovery of fluorescence intensity was monitored for 5 minutes. The ER region regained the fluorescence almost completely within 3 minutes, while the nuclear envelope region recovered slowly and only partially (Fig. 7).
A. Example of the photobleaching process in the perinuclear region and ER (boxes). The recovery is shown at 0, 10 and 300 seconds after bleaching. B, Lower panel shows the average normalized fluorescent intensity during recovery from all cells (±s.e.m.). The first 10 data points were taken every 0.47 seconds, the next 15 every 5 seconds and the last 15 every 20 seconds. The black solid lines are the result of fitting as described in Material and Methods. The initial 40 seconds of recovery are shown normalized in the inset.
Quantitatively, nuclear envelope KV10.1 showed a smaller mobile fraction than ER KV10.1 (54.3±4.3%, n = 38 compared to 89.9±4.9%, n = 33, p<0.001) and also a reduced diffusion coefficient (4.4±0.8x 10−3 µm2/s, n = 38 compared to 10.3±2.1x 10−3 µm2/s, n = 33, p<0.001). These parameters are consistent with those reported for other INM proteins , , ,  and meet the criteria of an INM-targeted protein. Again, the significant amount of immobile KV10.1 and the restricted diffusion of the remaining mobile protein suggest to a tight interaction of KV10.1 with its INM environment.
Subcellular fractionation of KV10.1 is compatible with INM localization
We then set out to confirm the localization of KV10.1 to the INM using biochemical tools. We purified nuclei from rat brain as described in the Methods section. After ultracentrifugation through sucrose cushions, nuclei were treated with citraconic anhydride, which is described to specifically remove the ONM , . The presence of KV10.1 and the well-established INM proteins lamina-associated polypeptide 2 (LAP2) and LUMA was investigated in the different fractions by western blot. KV10.1, LAP2 and LUMA were all present predominantly in the nuclear fraction in comparison to the total brain homogenate (Fig. 8A). Removal of the ONM by citraconic anhydride (demonstrated by a>10-fold reduction in cytocrome c reductase activity) resulted in a concurrent enrichment of all three proteins, strongly suggesting that KV10.1 is present in the INM in physiological conditions. In transfected HEK293 cells, we also observed that a substantial amount of KV10.1 was detected in the nuclear membrane fraction and could be further enriched with LAP2 and LUMA by citraconic anhydride treatment (Fig. 8B).
The nuclear membrane fraction either from rat brain homogenate (A, n = 3) or HEK293 cells stably expressing KV10.1 (B, n = 4) was sedimented by sucrose gradient ultracentrifugation and the ONM was further removed by citraconic anhydride treatment. Proteins from whole cell extract, nuclear fraction (lane 2) and nuclei without the ONM were immunoblotted using anti-KV10.1, anti-LUMA and anti-LAP2 antibodies. Quantification corresponds to the relative densitometry measurements for each lane (mean±s.e.m.).
The relative abundance of KV10.1 in nuclear versus extranuclear fractions was much more evident in brain extract than in transfected cells. This is compatible with ‘backed up’ localization previously observed in the overexpression of other INM proteins (LBR , MAN1 , nurim , LUMA  and emerin ); this phenomenon occurs when an excess of INM proteins saturates the INM retention sites, forcing accumulation in the ER (also observed by immunofluorescence studies in the case of KV10.1; data not shown).
Next, we addressed the questions whether KV10.1 at the INM comes directly from the ER, or rather has been properly targeted to the plasma membrane and only then transported to the nuclear compartment. We performed enzymatic surface-biotinylation experiments using a tagged KV10.1 channel that carries on an extracellular loop the acceptor peptide (AP) that is recognized and modified by the biotin protein ligase birA . After 20 minutes or 24 hours of biotinylation reaction, the modified proteins were pulled down and analyzed by western blot. Biotinylated KV10.1 was preferentially found in the nuclear fractions, and a significant fraction was resistant to Triton X-100 extraction, indicating INM localization (Fig. 9).
After enzymatic biotinylation, cytoplasmic and nuclear extracts were pulled down (A) with streptavidin-magnetic beads. KV10.1-AP was detected in the nuclear fraction and resistant to detergent extraction. As a control, (B) shows the total KV10.1-AP and LUMA signals from these extracts before pull-down of biotinylated Kv10.1-AP. Densitometry for each lane is represented below the corresponding blot (mean±s.e.m, n = 3).
Altogether, our results suggest a tight retention of perinuclear KV10.1, probably in association with detergent-resistant structures such as lamina or chromatin.
Single channel activity compatible with KV10.1 is detected in the INM
The above-described data do not answer the question whether the channel located at the INM is functionally active. We therefore set up to record single channels from both membranes of isolated nuclei either directly approaching the envelope for ONM measurement or after removal of the outer membrane with citraconic anhydride for INM recordings.
For these experiments, the permeability due to the NPC needs to be suppressed to unmask smaller currents. In the absence of Ca2+, which was our initial condition because of the strong inhibition of KV10.1 current in the presence of Ca2+-calmodulin , a large (1 nS) conductance was present in virtually every membrane patch. This current was more evident upon de- or hyper-polarization or mechanical stress. These currents could be inhibited by known nuclear pore current blockers (mAb414, wheat germ agglutinin , La3+ and Zn2+  and are therefore probably due to the NPC. Unfortunately, in our hands neither mAb414 nor wheat germ agglutinin induced complete inhibition. This made us rely on ionic blockers and to remove EGTA from the recording solution, although EGTA was still used throughout the purification process in an attempt to dissociate calmodulin from KV10.1. Addition of W-7, a calmodulin antagonist, did not significantly increase the chance of finding an active KV10.1 channel (data not shown), suggesting that calmodulin had indeed been effectively removed during EGTA washing. For recording, EGTA was thoroughly washed out and 10 µM La3+ was added to the solution. We chose this concentration because it had no evident effect on plasma membrane KV10.1, which is also inhibited by extracellular La3+ with an apparent IC50 of approximately 200 µM.
In asymmetrical potassium at 0 mV, we detected channel activity with a conductance compatible with KV10.1. In symmetrical potassium, large conductance activity was more frequently observed in untreated, ONM preparations. We were unable to record reliable single channel traces from them and they will not be discussed here further. On the other hand, of 64 citraconic anhydride-treated nuclei, 27 records still showed NPC current and were thereby excluded from further analysis, 17 nuclei showed no activity, while the remaining 20 showed comparatively small channel openings. These openings were compatible with KV10.1 in terms of conductance (8.1±0.4 pS; Fig. 10A, B) and voltage dependence, with highest open probability at −60 mV and lowest at +60 mV in the pipette, which would represent a membrane potential of opposite sign in an inside-out configuration, that is, if the extracellular side of the channel faces the pipette and the intracellular domains are located to the nucleoplasm. We did not detect any comparable activity in 11 NPC-current-free preparations from non-transfected cells. In asymmetrical K+, single channels with voltage dependence similar to the one expected for KV10.1, most remarkably the severe dependence of the activation time constant on the prepulse potential described for this channel and commonly used to identify it (see e.g. ref ) and a chord conductance of 8.3±0.6 pS was detected (Figure 10 B, C). To characterize the pharmacology of the channel, we used astemizole, a H1 histamine receptor inhibitor often used as blocker of KV10.1, because it has not been reported to block conductances other than those of the eag family including KV10.1 at a concentration of 2–5 µM. In asymmetrical potassium, we performed continuous recordings at 0 mV to avoid contamination by channels other than those selective for K+; under this condition, the activity compatible with KV10.1 virtually disappeared in 7/7 patches after application of astemizole. In those cases that allowed washout of the drug (3/7), the activity was recovered. Figure 11 A depicts a similar experiment, but performed at +60 mV to increase current amplitude. In symmetrical K+, this treatment reduced the open probability at +60 mV (membrane potential) by 94±10% (n = 5), also indicating a blockade of the channel by astemizole. Since the extracellular side of the channel appeared to be facing the pipette, we used mAb56, a monoclonal antibody reported to bind to the extracellular loops of KV10.1 and inhibit current . To do this, we performed layered loading of the pipette by backfilling the antibody-containing solution (45 µg/mL) over antibody-free solution, to allow recording of channel activity prior to the diffusion of the antibody to the pipette tip. The channel activity decreased in all patches tested (n = 6) within 10–20 minutes of the presence of mAb56, a time course compatible with the described action of mAb56 on KV10.1 whole-cell current in the plasma membrane (Fig. 11B). Under this experimental setup it is not possible to fully discard a spontaneous rundown of the current, which eventually would happen in any case, but we did not observe rundown in the time range used in these experiments. Due to the selectivity of mAb56, this result strongly supports the molecular identity of the detected channel as KV10.1, as well as the proposed orientation in the INM implied by the above experiments, namely that the intracellular C-terminus faces the nucleoplasm.
A. Amplitude histogram of events recorded at +40 mV in symmetrical potassium (pooled data from 5 independent recordings). B. Single channel amplitudes versus voltage in symmetrical (circles) or asymmetrical potassium (squares). Error bars represent s.e.m. The solid line represents a linear fitting of the data that gives a slope conductance of 8.1 and 8.3 pS. C. Traces recorded at +60 mV from a holding potential of −60 (blue) or −100 mV (red). The latency time before the first opening is increased when the holding potential is more negative, as clearly seen in the ensemble currents depicted in the inset. Scale bars: 2 pA, 500 ms.
A. Block by astemizole. Traces obtained at +60 mV in asymmetrical potassium before (control, black), during (astemizole, red) and after washing (wash, blue) 25 µM astemizole. Scale bars: 2 pA, 500 ms. B. Block by monoclonal antibody mAb56. Control trace, immediately after seal formation at −80 mV in the pipette (black), symmetrical potassium. Red: Recording after 20 minutes incubation at the same voltage Scale bars: 0.5 pA, 500 ms.
In addition to the activity attributed to KV10.1, it is noteworthy that we also detected other conductances in the range of 20–40 pS, which were unaffected by astemizole or mAb56.
In contrast to traditional ideas, the nuclear envelope is increasingly viewed as a permeability barrier to ions. Although the NPC is generally believed to be responsible for the most of the permeability of the nuclear envelope, there is no correlation between NPC density and the resistivity of the nuclear envelope . In addition, the intranuclear voltage is dependent on cytoplasmic potassium concentration and independent of membrane potential . Therefore, the NPC should be impermeable to small ions in a physiological environment. The ONM, on the other hand, seems to be quite leaky to small molecules, including ions . In this scenario, the structure responsible for the ionic and electrical differences between the nucleoplasm and cytoplasm should be the INM, and ion channels in this membrane would therefore become relevant.
We report here, for the first time, the presence of a functional voltage-gated (the InsP3 receptor is a ligand-gated Ca2+ channel) ion channel with a defined molecular identity in the INM. This statement is based on both optical and electron microscope data as well as biochemical evidence, both in native and heterologous systems. It not only fulfills all the criteria of a transmembrane protein localized to INM but it is also functional as an ion channel conducting potassium. The evidence in favor of an INM localization include i) inaccessibility to channel-specific antibodies after digitonin permeabilization, ii) resistance to Triton X-100 extraction, iii) limited lateral diffusion, iv) co-segregation with established INM markers and v) electron microscopy. We have used citraconic anhydride to remove the ONM. Other reports have used citric acid or Triton X-100 for the same purpose, but both have the disadvantage that they can also extract INM proteins and make electrophysiological recordings more difficult , . Additionally, our electrophysiological experiments indicate the protein orientation; the extracellular loops of the channel face the pipette, which favors localization at the INM. The identity of the channel as KV10.1 is supported not only by the fact that it is not found in wild-type nuclei, but also by its voltage dependence-particularly dependence on the prepulse potential-single channel conductance and pharmacology, most importantly by the inhibition measured in the presence of mAb56, which is the most selective blocker available.
We have devoted substantial efforts to make sure that this distribution is not an overexpression artifact. First, INM localization was also observed in native expression systems with immunoelectron microscopy and subcellular fractionation. Second, even in heterologous systems, the expression level in the perinuclear region is not correlated with the level in the cytoplasm, and protein synthesis inhibition does not alter the perinuclear localization, arguing against aberrant relocation of excess KV10.1. Third, a significant fraction of the AP tagged protein at the INM has been exposed to the extracellular medium and does not move directly from the ER to the nuclear envelope, arguing against saturation of the transport machinery. We cannot exclude localization also in the ONM, especially in overexpression systems, but the specificity of this localization is more difficult to establish.
Two major types of NLS have been described in the soluble nucleoplasmic proteins SV40 large T antigen and nucleoplasmin. Similar NLS have been predicted in the nucleoplasmic domains of many INM proteins  and most of them reside in regions essential for INM localization, as determined by deletion studies (for emerin , MAN1  and LEM2 , but not for LAP2-β ). LBR shows a NLS in its nucleoplasmic domain, but can also be targeted by its transmembrane domain . On the other hand, there is no predicted NLS for nurim, and LUMA has a predicted NLS in its luminal domain , and both nurim and LUMA depend on their transmembrane domains for targeting to the INM , . SUN-2 bears two NLS at the nucleoplasmic domain, but can be targeted by its luminal domain, which possesses no known NLS . In a similar way, while a conserved bipartite NLS can be identified in the nucleoplasmic domain of KV10.1, its deletion however does not significantly alter the INM localization. Since the size of the nucleoplasmic domain of INM proteins able to pass through the NPC during interphase is small (<75 kDa)  and the fact that KV10.1 is only functional as a tetramer, it is also possible that it is targeted to the INM during reassembly of nuclear envelope in mitosis. However, the relatively fast localization of biotinylated KV10.1 to the INM (Fig. 9) would not be explained by such a mechanism.
The function of KV10.1 at this location remains only speculative. It could partly underlie the oncogenic properties of the channel. INM proteins play a role in gene expression regulation  either by sequestering transcription factors, repressors or other regulators or by direct interaction with chromatin. Within the chromatin in the vicinity of the nuclear envelope, genes encoded in areas close to the NPC are being actively transcribed, while those located away from the NPC (in heterochromatin) are often silent. We did not observe a direct physical interaction of KV10.1 with heterochromatin, but the presence of the channel correlated with the absence of NPC and epitope masking of lamin A/C, which is compatible with enrichment in heterochromatin. The physical structure of heterochromatin influences not only transcription efficiency but also splicing , . Additionally, K+ ions increase the stability of G-quadruplex structures ,  (inter or intramolecular non Watson-Crick pairs in guanine-rich areas), which can act as transcriptional repressor elements (for example of the myc oncogene ). There is also abundant evidence of crosstalk between INM proteins and proteins involved in signaling pathways associated with cell cycle or carcinogenesis . Results from our laboratory unequivocally point to a crucial role of KV10.1 channels at the plasma membrane, because a functional antibody that blocks the current shows antitumor activity in vivo, and it can exert its action only on exposed channels . The present report indicates a cross talk between the pools of KV10.1 at the plasma membrane and at the INM. This is conceptually similar to the role of the C-terminus of a voltage-gated calcium channel, which is cleaved and acts as a transcription factor . There are also descriptions of transmembrane proteins that are translocated from the plasma membrane to the INM . Further experiments to clarify this question are certainly warranted.
Materials and Methods
Cell culture and transfection
CHO-K1 (ACC 110), HEK293 (ACC 305), HeLa (ACC 57), MCF-7 (ACC 115), and NIH3T3 (ACC 59) cells (all obtained from DSMZ, Braunschweig, Germany) were grown, respectively, in Ham's F12 Nutrient mix, DMEM:F12, MEM, RPMI1640 and DMEM medium, supplemented with 10% FCS at 37°C in a humidified atmosphere with 5% CO2. Cells stably expressing KV10.1 (HEK-KV10.1 and HEK-KV10.1-AP) were cultured in the medium of the respective parental cell lines supplemented with Zeocin (Calya, 3 µg/mL).
EGFP-KV10.1 was produced by cloning the open reading frame of KV10.1 into pEGFPC2 (Clontech). To do this, an EcoRV site was introduced at the start codon of KV10.1. KV10.1-DsRed and KV10.1-DsRed2 were generated by introducing a SacI site at the termination codon of KV10.1 and then cloning the full ORF into pDsRedN1 and pDsRed2N1 (Clontech). The nuclear localization signal was deleted by PCR. The pCDNA3.1 KV10.1-mVenus construct was generated by replacing the stop codon of KV10.1 by three alanine residues and inserting the coding sequence of mVenus in frame (a mutant Venus-L221K- with less tendency to multimerize). The full coding region was sequenced to ensure that no additional mutation(s) had been introduced.
To mark surface expressed KV10.1, the acceptor peptide for biotin ligase (AP) was inserted between the S3 and S4 loops of the channel. This peptide is recognized and biotinylated by the enzyme (BirA), which has only access to exposed parts. The sequence: TGSSGSGSGGLNDIFEAQKIEWHEGGAGGAAGGTG was inserted after residue E317 of KV10.1 to produce KV10.1-AP.
All tagged-KV10.1 exhibit the electrophysiological characteristics of KV10.1 in heterologous expression systems (data not shown). For transfection experiments, cells were plated on glass coverslips and transfected at 70–90% confluence using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions. Immunofluorescence staining and photobleaching experiments were carried out 16–30 hours after transfection.
Mouse monoclonal and rabbit polyclonal anti-KV10.1 antibodies were generated in our laboratory and have been described elsewhere . mAb33 and polyclonal antibodies (2413 and 9391) recognize the C-terminus of KV10.1, while mAb62, mAb66 and mAb56 bind to the extracellular S5-S6 linker. For double staining of the NPC and KV10.1, a commercial rabbit polyclonal antibody was used (Alomone, Jerusalem, Israel).
Other antibodies used were goat anti human lamin A/C (Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-NPC monoclonal antibody (mAb414, Abcam, Cambride, UK), rabbit polyclonal anti-LAP2, which recognizes only the transmembrane isoforms in LAP2 family, and anti-LUMA antibodies (kindly provided by Henning Otto, Freie Universität Berlin, Germany).
For double staining of the NPC and KV10.1 , cells were washed with TBS and fixed with 2% formalin solution (Sigma) for 15 minutes at room temperature. The reaction was quenched with 50 mM glycine for 5 minutes in HMK buffer (20 mM HEPES, 1 mM MgCl2, 100 mM KCl, pH 7.5), and the cells rinsed with HMK, permeabilized with 0.5% Triton X-100 (Sigma) in HMK for 5 minutes and incubated in 10% normal goat serum (NGS) in HMK for 30 minutes. The cells were sequentially incubated with rabbit anti-KV10.1 (1∶1000, Alomone) in HMK buffer supplemented with 1% NGS, AlexaFluor 488 anti-rabbit antibody (1∶1000, Invitrogen), 1 µg/mL mouse anti-NPC and AlexaFluor 680-labeled anti-mouse antibody (1∶1000 Invitrogen). Between KV10.1 and NPC staining, we introduced a blocking step with 10% NGS in HMK for 30 minutes. The coverslips were mounted using DAPI-containing ProLong Gold Antifade reagent (Invitrogen).
Lamin A/C staining and unmasking was performed as described in (Isokane, Hieda et al. 2008) with modifications. Briefly, CHO cells transiently expressing KV10.1-mVenus were permeabilized for 10 minutes on ice in 20 mM Tris-HCl, 3 mM MgCl2, 0.5 mM CuCl2, pH 7.5 with 0.4% Triton X-100. Then the cells were extracted either on ice for 5 minutes with 0.5 M NaCl or at 37°C for 20 minutes with DNase I (Qiagen, 80 U/mL) or DNase I plus 0.5 M NaCl, washed, fixed and then blocked in TBS plus 3% BSA for 1 hour, stained for 3 hours at 37°C against lamin A/C at 1∶100 dilution (Santa Cruz) and probed with anti-goat AlexaFluor secondary antibodies (1∶2000, 1 hour).
Detergent extraction and permeabilization experiments
For Triton X-100 extraction experiments, CHO cells transfected with KV10.1-mVenus were incubated on ice for 5 minutes with or without 3% Triton X-100 in extraction buffer  (10 mM HEPES, 80 mM KCl, 16 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, 30% glycerol, and protease inhibitor mixture -Complete, Roche Applied Science, pH 7.9). The cells were then fixed in 4% p-formaldehyde at room temperature for 15 minutes and incubated with 50 mM NH4Cl in PBS for 10 minutes and mounted.
Digitonin permeabilization experiments were performed as described in , with modifications. CHO cells transfected with KV10.1-mVenus were fixed with 4% paraformaldehyde for 10 minutes at room temperature and incubated for 10 minutes in 50 mM NH4Cl in PBS. After that, the cells were incubated for 5 minutes at 4°C in 40 µg/mL digitonin (diluted from a 20 mg/mL DMSO stock), or 0.5% Triton X-100 in PBS. After a blocking step with 10% BSA in PBS for 30 minutes, the cells were incubated with the desired primary antibodies (either mAb66 or mAb33, 0.5 µg/mL) for 1 h in TBS and anti-mouse AlexaFluor 546 secondary antibodies (1∶1000, 30 minutes).
Fluorescence signals were collected with the equipment indicated in each Figure. Wide field epifluorescence images were obtained in a Zeiss Axioskop 2 microscope equipped with a SPOT 1.3 camera and using the SPOT software. Confocal microscopy was performed in a laser scanning confocal microscope (TCS-SP2; Leica) using an oil immersion objective (HCX PL Apo, 63×/NA = 1.4) or a Zeiss LSM 510 Meta device using a Plan-Neofluar 40x/1.3 Oil DIC objective. ImageJ  and Adobe Photoshop were used for offline image processing. No non-linear image modifications were performed. The JACoP plug-in  was used to quantify the co-localization of KV10.1 and NPC, and the “Straighten Curved Objects” plugin  for the straightened view shown in Figure 4C.
Nuclear isolation, surface labeling and western blot
Whole cell lysates were obtained by homogenization in denaturing lysis buffer (50 mM NaHCO3, 15 mM Na2CO3, 2% SDS). For Triton X-100 extraction experiments, nuclear preparations were obtained using the NucBuster Nuclear Protein Extraction Kit (Novagen, Darmstadt, Germany) according to the manufacturer's manual except for the addition of an extraction step of the nuclear pellet in extraction buffer +0.5% Triton X-100. Cytochrome c assay was performed as described in .
For nuclear protein preparation, the nuclei were prepared by homogenizing HEK-KV10.1 cells in hypotonic solution or minced rat brain in nuclear isolation medium (NIM, 0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 10 mM Tris/HCl, pH 7.4). The crude nuclear extracts were then washed twice in NIM. The nuclei were resuspended in one volume of NIM and then mixed with two volumes of a sucrose density barrier (SDB: 2.3 M sucrose, 25 mM KCl, 5 mM Tris/HCl, pH 7.4). The whole mixtures were laid on top of SDB and centrifuged at 100,000 xg for one hour. The pellets containing nuclei were subjected to citraconic anhydride to remove the ONM as described by . Then the nuclear proteins were prepared by the low-ionic-strength method .
For western blots, proteins were separated in a 3–8% gradient polyacrylamide gel electrophoresis (Invitrogen), transferred to nitrocellulose membranes and probed with KV10.1 antibodies (9391). The same membranes were subsequently stripped (Restore Western Blot Stripping Buffer, Thermo Scientific) and re-probed with anti-LAP2 (1∶2000) and anti-LUMA (1∶2000).
To label surface-expressed KV10.1-AP by enzymatic biotinylation, stably transfected HEK293 cells were incubated for 20 minutes at 37°C in 10 µM biotin and 120 nM BirA (Avidity, USA) in PBS (containing 4 mM MgCl2 and 1 mM ATP). For 24 hours continuous labeling, after the described incubation, culture medium supplemented with 1 mM ATP, 10 µM biotin, 30 mM di-sodium phosphocreatine and 30 U/mL creatine phosphokinase was added to the reaction.
Biotin-labeled proteins were pulled-down in 2 mL NPE lysis buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl, 5 mM KCl, 1% NP-40, Complete Protease-inhibitors (Roche), pH 7.5) with 30 µL Dynabeads MyOne Streptavidin T1 (Invitrogen) for one hour at 4°C. The beads were then washed three times in NPE, once in TBS and the proteins were recovered in NuPAGE loading buffer.
Nuclei from HEK-KV10.1 cells were prepared essentially as those for biochemical analysis with the addition of 10 mM EGTA to all solutions. After sedimentation through a 2.3 M sucrose cushion, nuclei were resuspended in NIM for ONM measurements. For INM measurements, nuclei were further treated with citraconic anhydride in modification buffer (200 mM HEPES/NaOH pH 8.5, 1 mM MgCl2, 250 mM sucrose) and washed twice in NIM solution. The nuclei were stored at 4°C in NIM and measured within 36 hours of preparation.
Single channel recordings were performed using bath solution 150 mM KCl, 5 mM MgCl2, 10 µM LaCl3, 10 mM HEPES/KOH pH 7.4. The pipette solution for symmetrical K+ recordings was identical to the bath solution except that 200 µM CaCl2 was added to improve seal formation. For recording in asymmetrical K+, the pipette contained 160 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 µM LaCl3, 8 mM glucose, 10 mM HEPES/NaOH, pH 7.4. The osmolarity of all solutions was 300–330 mmol/kg. Nuclei in suspension were allowed to attach to the plastic bottom of the experimental chamber or to a poly-L-Lysine- coated coverslip for 5 minutes and were then gravity perfused extensively with bath solution to remove trace amounts of EGTA. Ellipsoid nuclei without attached membrane debris were selected visually for measurement. Currents were recorded using an EPC9 patch-clamp amplifier (HEKA Elektronik, Lambrecht, Germany) in the “nucleus-attached” configuration. This is equivalent to the standard cell-attached configuration for the INM, but outside-out for the ONM. Pulse generation and data acquisition were controlled with Pulse software (HEKA Elektronik). Data were filtered at 1 kHz and digitized at 5 kHz. Patch pipettes were pulled from WPI.PG10165-4 glass (World precision Instruments) or Hilgenberg thick-wall (0.5 mm) borosilicate with a resistance of 7–12 MΩ. Offline data analysis was performed using TAC (Bruxton Corp. Seattle, US.). Astemizole (Sigma) was prepared in 10 mM stock solution in DMSO and used at 1∶5000 dilution shielded from light. Solution exchanges were completed in 5 minutes. For antibody blockage, the tip of pipette was loaded with normal pipette solution and the pipette was then backfilled with 300 nM mAb56. All electrophysiological experiments were performed at room temperature (20–22°C).
Fluorescence recovery after photobleaching (FRAP)
CHO cells plated on 40 mm coverslips were transfected as described above. Immediately before FRAP experiments, cells were incubated with Hoechst 33342 (50 ng/mL, 5 minutes at room temperature) to stain the nuclei and washed twice with TBS. FRAP was performed using a 40x, HCX PL Fluotar, 1.25 NA oil immersion objective on a Leica TCS SP II confocal microscope installed in a temperature controlled chamber. Parameters were identical in all experiments; cells were kept at 37°C in a Focht Live-Cell Chamber System (Bioptechs Inc, Butler, US.) in extracellular solution (160 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 8 mM Glucose, 10 mM HEPES/NaOH pH 7.4.). At a spatial sampling frequency of 40 nm, two 2 µm strips either on the perinuclear region or through the cytoplasm were chosen as regions of interest (ROI). The cells were scanned at 1400 Hz with Ar 514 laser at transmission of 7% every 0.47 seconds for 5 times before bleaching as the reference images, in 12-bit, 512×512 pixels format and then ROI were bleached 20 times at 100% transmission. The first 10, 15 and the last 15 post-bleached images were taken every 0.47, 5 and 20 seconds correspondingly. The emission light was collected in the range of 527 nm to 608 nm.
All the images were background-subtracted and then all the post-bleach images were corrected for photobleaching on the principle that the fluorescence intensity of whole post-bleached images should stay the same as the intensity outside the ROI in the reference images. Then the time-lapse images were corrected for lateral drift using StackReg .
The fluorescence intensities of the ROIs were normalized to a function of time .(1)
F (t) is the fluorescence intensity of the ROI at time t. F0 is the ROI intensity of the first post-bleach image and Fpre is the average ROI intensity of the first 5 reference images. F (t) ' is the ROI fractional fluorescence intensity at time t. The diffusion coefficient D was calculated by fitting the data with :(2) where D is the one-dimensional diffusion constant; ω is the width of the strip or the square, (2 µm in our case). t0 was taken as the midpoint of the last bleach. F(∞) is the value of asymptote when t approaches infinity. All the data fitting was processed by Igor Pro 6.0.2 (WaveMetrics, Inc. Lake Oswego, OR).
Freeze-substitution and postembedding immunogold labeling
MCF7 cells (DSMZ, see above) and hippocampal and cerebellar slices from 3 Sprague-Dawley rats (Harlan Research Laboratories) were used for freeze substitution. Cell cultures were immersion fixed with 4% paraformaldehyde and 0.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.15, for 1.5 hours. Rats for the hippocampal and cerebellar analysis were transcardially perfused and post-fixed with the same fixative. After fixation, a freeze substitution protocol similar to that described previously was used , . Hippocampal and cerebellar regions were carefully dissected and processed for freeze-substitution and low-temperature embedding. For post-embedding immunocytochemistry, ultrathin sections (80 nm in thickness) on nickel grids were incubated in sodium borohydride and glycine in Tris-buffered saline solution with Triton X-100. After being pre-blocked with serum, the sections were incubated with affinity-purified primary antibody mAb62 (1 µg/mL; 1∶200 dilution). Primary antibody was detected with secondary antibodies conjugated to 5 nm gold particles (1∶20; Amersham, Arlington Heights, USA). In some ultrathin sections from cerebellum, the gold conjugated secondary antibody was silver intensified using the Aurion silver enhancement kit (Aurion, Wageningen, The Netherlands).The specificity of the antibody has been established previously . Controls included omitting mAb62 and pre-absorption of mAb62 with the corresponding blocking protein (10 µg/mL final concentration). Ultrathin sections were counterstained with uranyl acetate and lead citrate and studied with a transmission electron microscope. Electron micrographs were taken at 30,000x magnification and scanned at a resolution of 3600 dpi using a Linotype-Hell scanner (Heidelberg, Germany). Image processing was performed with Adobe Photoshop using only the brightness and contrast commands to enhance gold particles.
None of the experiments reported here required human material, and therefore ethical approval was not necessary. The experimental procedures on rats were approved and supervised by the University of Connecticut Institutional Animal Care and Use Committee (IACUC-A08.037) in accordance with NIH guidelines.
We thank Dr. Èva Lörinczi for help in electrophysiological experiments, Prof. Henning Otto for the anti-LUMA and anti-LAP2 antibodies, Xiao Jie Huang for help with the FRAP experiments and Víctor Díaz-Salamanca, Michael Kothe, Barbara Scheufler and Annett Sporning for excellent technical assistance.
Conceived and designed the experiments: YC AS MER TK LAP WS. Performed the experiments: YC AS MER LAP. Analyzed the data: YC AS MER TK LAP WS. Contributed reagents/materials/analysis tools: TK LAP. Wrote the paper: YC AS MER TK LAP WS.
- 1. Hemmerlein B, Weseloh RM, de Queiroz FM, Knötgen H, Sánchez A, et al. (2006) Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer 5: 41.
- 2. Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, et al. (2007) Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 13: 824–831.
- 3. Ding XW, Luo HS, Jin X, Yan JJ, Ai YW (2007) Aberrant expression of Eag1 potassium channels in gastric cancer patients and cell lines. Med Oncol 24: 345–350.
- 4. Ding XW, Yan JJ, An P, Lu P, Luo HS (2007) Aberrant expression of ether a go-go potassium channel in colorectal cancer patients and cell lines. World J Gastroenterol 13: 1257–1261.
- 5. Roy J, Vantol B, Cowley EA, Blay J, Linsdell P (2008) Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line MCF-7. Oncol Rep 19: 1511–1516.
- 6. Wadhwa S, Wadhwa P, Dinda AK, Gupta NP (2008) Differential expression of potassium ion channels in human renal cell carcinoma. Int Urol Nephrol.
- 7. Ding XW, Wang XG, Luo HS, Tan SY, Gao S, et al. (2008) Expression and prognostic roles of Eag1 in resected esophageal squamous cell carcinomas. Dig Dis Sci 53: 2039–2044.
- 8. Mello de Queiroz F, Suarez-Kurtz G, Stuhmer W, Pardo LA (2006) Ether a go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer 5: 42.
- 9. Agarwal J, Griesinger F, Stuhmer W, Pardo L (2010) The potassium channel Ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Molecular Cancer 9: 18.
- 10. Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, et al. (1999) Oncogenic potential of EAG K(+) channels. Embo J 18: 5540–5547.
- 11. Downie BR, Sanchez A, Knotgen H, Contreras-Jurado C, Gymnopoulos M, et al. (2008) Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J Biol Chem 283: 36234–36240.
- 12. Gomez-Varela D, Zwick-Wallasch E, Knotgen H, Sanchez A, Hettmann T, et al. (2007) Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 67: 7343–7349.
- 13. Hegle AP, Marble DD, Wilson GF (2006) A voltage-driven switch for ion-independent signaling by ether-à-go-go K+ channels. Proc Natl Acad Sci U S A 103: 2886–2891.
- 14. Napp J, Monje F, Stuhmer W, Pardo LA (2005) Glycosylation of Eag1 (Kv10.1) potassium channels: intracellular trafficking and functional consequences. J Biol Chem 280: 29506–29512.
- 15. Martin S, de Oliveira CL, de Queiroz FM, Pardo LA, Stühmer W, et al. (2008) Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain. Neuroscience 155: 833–844.
- 16. Diaz L, Ceja-Ochoa I, Restrepo-Angulo I, Larrea F, Avila-Chavez E, et al. (2009) Estrogens and human papilloma virus oncogenes regulate human ether-a-go-go-1 potassium channel expression. Cancer Res 69: 3300–3307.
- 17. Terry LJ, Shows EB, Wente SR (2007) Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318: 1412–1416.
- 18. Schirmer EC, Gerace L (2005) The nuclear membrane proteome: extending the envelope. Trends Biochem Sci 30: 551–558.
- 19. Schirmer EC, Foisner R (2007) Proteins that associate with lamins: many faces, many functions. Exp Cell Res 313: 2167–2179.
- 20. Mazzanti M, Bustamante JO, Oberleithner H (2001) Electrical dimension of the nuclear envelope. Physiol Rev 81: 1–19.
- 21. Marchenko SM, Yarotskyy VV, Kovalenko TN, Kostyuk PG, Thomas RC (2005) Spontaneously active and InsP3-activated ion channels in cell nuclei from rat cerebellar Purkinje and granule neurones. J Physiol 565: 897–910.
- 22. Longin AS, Mezin P, Favier A, Verdetti J (1997) Presence of zinc and calcium permeant channels in the inner membrane of the nuclear envelope. Biochem Biophys Res Commun 235: 236–241.
- 23. Rousseau E, Michaud C, Lefebvre D, Proteau S, Decrouy A (1996) Reconstitution of ionic channels from inner and outer membranes of mammalian cardiac nuclei. Biophys J 70: 703–714.
- 24. Fedorenko O, Yarotskyy V, Duzhyy D, Marchenko S (2010) The large-conductance ion channels in the nuclear envelope of central neurons. Pflugers Archiv : European journal of physiology 460: 1045–1050.
- 25. Kowarski D, Shuman H, Somlyo AP, Somlyo AV (1985) Calcium release by noradrenaline from central sarcoplasmic reticulum in rabbit main pulmonary artery smooth muscle. J Physiol 366: 153–175.
- 26. Hoffman JF, Geibel JP (2005) Fluorescent imaging of Cl- in Amphiuma red blood cells: how the nuclear exclusion of Cl- affects the plasma membrane potential. Proc Natl Acad Sci U S A 102: 921–926.
- 27. Mazzanti M, DeFelice LJ, Cohn J, Malter H (1990) Ion channels in the nuclear envelope. Nature 343: 764–767.
- 28. Bustamante JO (2006) Current concepts in nuclear pore electrophysiology. Can J Physiol Pharmacol 84: 347–365.
- 29. Bootman MD, Fearnley C, Smyrnias I, MacDonald F, Roderick HL (2009) An update on nuclear calcium signalling. J Cell Sci 122: 2337–2350.
- 30. Pezer Z, Ugarković D (2008) Role of non-coding RNA and heterochromatin in aneuploidy and cancer. Semin Cancer Biol 18: 123–130.
- 31. Stewart CL, Roux KJ, Burke B (2007) Blurring the boundary: the nuclear envelope extends its reach. Science 318: 1408–1412.
- 32. Adam SA, Marr RS, Gerace L (1990) Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors. J Cell Biol 111: 807–816.
- 33. Deutsch C (2003) The Birth of a Channel. Neuron 40: 265–276.
- 34. Rolls MM, Stein PA, Taylor SS, Ha E, McKeon F, et al. (1999) A visual screen of a GFP-fusion library identifies a new type of nuclear envelope membrane protein. J Cell Biol 146: 29–44.
- 35. Maeshima K, Yahata K, Sasaki Y, Nakatomi R, Tachibana T, et al. (2006) Cell-cycle-dependent dynamics of nuclear pores: pore-free islands and lamins. J Cell Sci 119: 4442–4451.
- 36. Bailer SM, Eppenberger HM, Griffiths G, Nigg EA (1991) Characterization of A 54-kD protein of the inner nuclear membrane: evidence for cell cycle-dependent interaction with the nuclear lamina. J Cell Biol 114: 389–400.
- 37. Makatsori D, Kourmouli N, Polioudaki H, Shultz LD, McLean K, et al. (2004) The inner nuclear membrane protein lamin B receptor forms distinct microdomains and links epigenetically marked chromatin to the nuclear envelope. J Biol Chem 279: 25567–25573.
- 38. Hieda M, Isokane M, Koizumi M, Higashi C, Tachibana T, et al. (2008) Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane. J Cell Biol 180: 763–769.
- 39. Dyer JA, Kill IR, Pugh G, Quinlan RA, Lane EB, et al. (1997) Cell cycle changes in A-type lamin associations detected in human dermal fibroblasts using monoclonal antibodies. Chromosome Res 5: 383–394.
- 40. Hozak P, Sasseville AM, Raymond Y, Cook PR (1995) Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J Cell Sci 108 (Pt 2): 635–644.
- 41. Hofemeister H, O'Hare P (2005) Analysis of the localization and topology of nurim, a polytopic protein tightly associated with the inner nuclear membrane. J Biol Chem 280: 2512–2521.
- 42. Ellenberg J, Siggia ED, Moreira JE, Smith CL, Presley JF, et al. (1997) Nuclear membrane dynamics and reassembly in living cells: targeting of an inner nuclear membrane protein in interphase and mitosis. J Cell Biol 138: 1193–1206.
- 43. Ostlund C, Ellenberg J, Hallberg E, Lippincott-Schwartz J, Worman HJ (1999) Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein. J Cell Sci 112 (Pt 11): 1709–1719.
- 44. Wu W, Lin F, Worman HJ (2002) Intracellular trafficking of MAN1, an integral protein of the nuclear envelope inner membrane. J Cell Sci 115: 1361–1371.
- 45. Schindler M, Holland JF, Hogan M (1985) Lateral diffusion in nuclear membranes. J Cell Biol 100: 1408–1414.
- 46. Schindler M (1984) Alterations in nuclear anatomy by chemical modification of proteins in isolated rat liver nuclei. Exp Cell Res 150: 84–96.
- 47. Lin F, Blake DL, Callebaut I, Skerjanc IS, Holmer L, et al. (2000) MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin. J Biol Chem 275: 4840–4847.
- 48. Bengtsson L, Otto H (2008) LUMA interacts with emerin and influences its distribution at the inner nuclear membrane. J Cell Sci 121: 536–548.
- 49. Howarth M, Ting AY (2008) Imaging proteins in live mammalian cells with biotin ligase and monovalent streptavidin. Nat Protoc 3: 534–545.
- 50. Schonherr R, Lober K, Heinemann SH (2000) Inhibition of human ether a go-go potassium channels by Ca(2+)/calmodulin. Embo J 19: 3263–3271.
- 51. Bustamante JO, Hanover JA, Liepins A (1995) The ion channel behavior of the nuclear pore complex. J Membr Biol 146: 239–251.
- 52. Bustamante JO (1993) Restricted ion flow at the nuclear envelope of cardiac myocytes. Biophys J 64: 1735–1749.
- 53. Lizák B, Csala M, Benedetti A, Bánhegyi G (2008) The translocon and the non-specific transport of small molecules in the endoplasmic reticulum (Review). Mol Membr Biol 25: 95–101.
- 54. Rosenberger U, Shakibaei M, Weise C, Franke P, Buchner K (1995) Citric acid extracts a specific set of proteins from isolated cell nuclei. J Cell Biochem 59: 177–185.
- 55. Schirmer EC, Florens L, Guan T, Yates JR, Gerace L (2003) Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science 301: 1380–1382.
- 56. Lusk CP, Blobel G, King MC (2007) Highway to the inner nuclear membrane: rules for the road. Nat Rev Mol Cell Biol 8: 414–420.
- 57. Brachner A, Reipert S, Foisner R, Gotzmann J (2005) LEM2 is a novel MAN1-related inner nuclear membrane protein associated with A-type lamins. J Cell Sci 118: 5797–5810.
- 58. Furukawa K, Panté N, Aebi U, Gerace L (1995) Cloning of a cDNA for lamina-associated polypeptide 2 (LAP2) and identification of regions that specify targeting to the nuclear envelope. EMBO J 14: 1626–1636.
- 59. Soullam B, Worman HJ (1995) Signals and structural features involved in integral membrane protein targeting to the inner nuclear membrane. J Cell Biol 130: 15–27.
- 60. Turgay Y, Ungricht R, Rothballer A, Kiss A, Csucs G, et al. (2010) A classical NLS and the SUN domain contribute to the targeting of SUN2 to the inner nuclear membrane. EMBO J 29: 2262–2275.
- 61. Heessen S, Fornerod M (2007) The inner nuclear envelope as a transcription factor resting place. EMBO Rep 8: 914–919.
- 62. Tilgner H, Nikolaou C, Althammer S, Sammeth M, Beato M, et al. (2009) Nucleosome positioning as a determinant of exon recognition. Nat Struct Mol Biol 16: 996–1001.
- 63. Alló M, Buggiano V, Fededa JP, Petrillo E, Schor I, et al. (2009) Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat Struct Mol Biol 16: 717–724.
- 64. Sen D, Gilbert W (1990) A sodium-potassium switch in the formation of four-stranded G4-DNA. Nature 344: 410–414.
- 65. Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH (2002) Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci U S A 99: 11593–11598.
- 66. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL (2005) The nuclear lamina comes of age. Nat Rev Mol Cell Biol 6: 21–31.
- 67. Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, Dolmetsch R (2006) The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor. Cell 127: 591–606.
- 68. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image Processing with ImageJ. Biophotonics International 11: 36–42.
- 69. Bolte S, Cordelières FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213–232.
- 70. Kocsis E, Trus BL, Steer CJ, Bisher ME, Steven AC (1991) Image averaging of flexible fibrous macromolecules: the clathrin triskelion has an elastic proximal segment. J Struct Biol 107: 6–14.
- 71. Graham JM (2001) Isolation of nuclei and nuclear membranes from animal tissues. Curr Protoc Cell Biol Chapter 3: Unit 3.10:
- 72. Thevenaz P, Ruttimann UE, Unser M (1998) A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process 7: 27–41.
- 73. Snapp EL, Altan N, Lippincott-Schwartz J (2003) Measuring protein mobility by photobleaching GFP chimeras in living cells. Curr Protoc Cell Biol Chapter 21: Unit 21.21:
- 74. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, et al. (2004) Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 101: 12543–12548.
- 75. Douyard J, Shen L, Huganir RL, Rubio ME (2007) Differential neuronal and glial expression of GluR1 AMPA receptor subunit and the scaffolding proteins SAP97 and 4.1N during rat cerebellar development. J Comp Neurol 502: 141–156.